Literature DB >> 8760740

Serum complex of trypsin 2 and alpha 1 antitrypsin as diagnostic and prognostic marker of acute pancreatitis: clinical study in consecutive patients.

J Hedström1, V Sainio, E Kemppainen, R Haapiainen, E Kivilaakso, T Schröder, J Leinonen, U H Stenman.   

Abstract

OBJECTIVE: To estimate the usefulness of serum concentrations of the complex of trypsin 2 and alpha 1 antitrypsin in diagnosing and assessing the severity of acute pancreatitis in comparison with serum C reactive protein, amylase, and trypsinogen 2 concentrations (reference markers).
DESIGN: Markers were measured in consecutive patients admitted with acute abdominal pain that was either due to pancreatitis or to other disease unrelated to the pancreas (controls).
SETTING: Department of surgery of a teaching hospital in Helsinki.
SUBJECTS: 110 patients with acute pancreatitis and 66 with acute abdominal diseases of extrapancreatic origin. On the basis of the clinical course, acute pancreatitis was classified as mild (82 patients) or severe (28 patients). MAIN OUTCOME MEASURES: Clinical diagnosis of acute pancreatitis and severity of the disease.
RESULTS: At admission all patients with acute pancreatitis had clearly raised concentrations of trypsin 2-alpha 1 antitrypsin complex (32 micrograms/l), whereas only three of the controls had such values. Of the markers studied, trypsin 2-alpha 1 antitrypsin complex had the largest area under the receiver operating curve, both in differentiating acute pancreatitis from extrapancreatic disease and in differentiating mild from severe disease.
CONCLUSIONS: Of the markers studied, trypsin 2-alpha 1 antitrypsin complex was the most accurate in differentiating between acute pancreatitis and extrapancreatic disease and in predicting a severe course for acute pancreatitis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8760740      PMCID: PMC2351744          DOI: 10.1136/bmj.313.7053.333

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  21 in total

1.  Quantitation of "acute-phase proteins" postoperatively. Value in detection and monitoring of complications.

Authors:  C L Fischer; C Gill; M G Forrester; R Nakamura
Journal:  Am J Clin Pathol       Date:  1976-11       Impact factor: 2.493

2.  A single-centre double-blind trial of Trasylol therapy in primary acute pancreatitis.

Authors:  C W Imrie; I S Benjamin; J C Ferguson; A J McKay; I Mackenzie; J O'Neill; L H Blumgart
Journal:  Br J Surg       Date:  1978-05       Impact factor: 6.939

3.  Computed tomography and acute pancreatitis.

Authors:  H G Dammann; E Grabbe; M Runge
Journal:  Lancet       Date:  1980-10-18       Impact factor: 79.321

4.  Studies on the turnover of endogenous cathodal trypsinogen in man.

Authors:  A Borgström; K Ohlsson
Journal:  Eur J Clin Invest       Date:  1978-12       Impact factor: 4.686

5.  Release of proteolytic enzymes in bile-induced pancreatitis in dogs.

Authors:  K Ohlsson; A Eddeland
Journal:  Gastroenterology       Date:  1975-09       Impact factor: 22.682

Review 6.  Amylase--its clinical significance: a review of the literature.

Authors:  W B Salt; S Schenker
Journal:  Medicine (Baltimore)       Date:  1976-07       Impact factor: 1.889

7.  The role of peritoneal lavage in severe acute pancreatitis.

Authors:  J H Ranson; F C Spencer
Journal:  Ann Surg       Date:  1978-05       Impact factor: 12.969

8.  Complementary use of ultrasound and computed tomography in studies of the pancreas and kidney.

Authors:  R G Levitt; G G Geisse; S S Sagel; R J Stanley; R G Evens; R E Koehler; R G Jost
Journal:  Radiology       Date:  1978-01       Impact factor: 11.105

9.  Plasma immunoreactive anionic pancreatic trypsin in cystic fibrosis.

Authors:  P R Durie; K J Gaskin; M C Geokas; M O'Rourke; C Largman
Journal:  J Pediatr Gastroenterol Nutr       Date:  1982       Impact factor: 2.839

10.  Time-resolved immunofluorometric assay of trypsin-2 complexed with alpha 1-antitrypsin in serum.

Authors:  J Hedström; J Leinonen; V Sainio; U H Stenman
Journal:  Clin Chem       Date:  1994-09       Impact factor: 8.327

View more
  13 in total

1.  Different patterns in immunoreactive anionic and cationic trypsinogen in urine and serum in human acute pancreatitis.

Authors:  U Petersson; S Appelros; A Borgström
Journal:  Int J Pancreatol       Date:  1999-06

2.  Pancreatitis may occur with a normal amylase concentration in hypertriglyceridaemia.

Authors:  P Sharma; S Lim; D James; R T Orchard; M Horne; C A Seymour
Journal:  BMJ       Date:  1996-11-16

3.  Membrane-protease interactions. III: A consideration of the difference in binding potential of pancreatic proteases to erythrocytes and erythrocyte ghosts.

Authors:  A S Brecher; M Rosen; D E Burkholder
Journal:  Dig Dis Sci       Date:  1999-09       Impact factor: 3.199

4.  Molecular forms of serum pancreatic stone protein in acute pancreatitis.

Authors:  Y Nakae; S Naruse; M Kitagawa; H Ishiguro; M Kato; S Hayakawa; T Kondo; T Hayakawa
Journal:  Int J Pancreatol       Date:  1999-02

5.  Serum macrophage migration inhibitory factor is an early marker of pancreatic necrosis in acute pancreatitis.

Authors:  Sakhawat H Rahman; Krishna V Menon; John H M Holmfield; Michael J McMahon; J Pierre Guillou
Journal:  Ann Surg       Date:  2007-02       Impact factor: 12.969

6.  Increased serum trypsinogen 2 and trypsin 2-alpha 1 antitrypsin complex values identify endoscopic retrograde cholangiopancreatography induced pancreatitis with high accuracy.

Authors:  E Kemppainen; J Hedström; P Puolakkainen; J Halttunen; V Sainio; R Haapiainen; E Kivilaakso; U H Stenman
Journal:  Gut       Date:  1997-11       Impact factor: 23.059

Review 7.  Serum amylase and lipase and urinary trypsinogen and amylase for diagnosis of acute pancreatitis.

Authors:  Gianluca Rompianesi; Angus Hann; Oluyemi Komolafe; Stephen P Pereira; Brian R Davidson; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2017-04-21

Review 8.  Acute pancreatitis: the substantial human and financial costs.

Authors:  J P Neoptolemos; M Raraty; M Finch; R Sutton
Journal:  Gut       Date:  1998-06       Impact factor: 23.059

9.  Serum levels of procarboxypeptidase B and its activation peptide in patients with acute pancreatitis and non-pancreatic diseases.

Authors:  C A Müller; S Appelros; W Uhl; M W Büchler; A Borgström
Journal:  Gut       Date:  2002-08       Impact factor: 23.059

10.  Peritoneal lavage with aprotinin in patients with severe acute pancreatitis. Effects on plasma and peritoneal levels of trypsin and leukocyte proteases and their major inhibitors.

Authors:  R Berling; A Borgström; K Ohlsson
Journal:  Int J Pancreatol       Date:  1998-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.